July's initial public offerings (IPO) continue to bring more variety to a market that was mostly biotech companies during the beginning of the coronavirus pandemic throughout the second quarter. Last week saw the introduction of three companies as well as three special purpose acquisition companies (SPAC) as market participants are ready now more than ever to shake off pandemic uncertainty. This week fairs to be no different for the last, with two Chinese offerings and two biotechs set to debut.
To recap last week's market, familiar face Dun & Bradstreet Holdings Inc.
Online self-serve renters and homeowners insurance platform Lemonade Inc.
Healthcare benefits platform Accolade Inc.
In addition to the new stocks, three SPACs also tapped into public markets: Goldman Sachs's
Looking ahead, China's largest LGBTQ-focused dating app BlueCity Holdings plans to raise $85 million from 5.3 million offered shares in the range of $15-$17. The on-demand workers platform Quhuo, which serves as the largest workforce solutions platform in China, aims to raise $27 million from 2.7 million shares priced between $9-$11. Nkarta, a preclinical oncology biotech, is slated to raise $150 million from 10 million shares priced in the range of $14-$16. Finally, the Phase 2 oncology biotech Poseida Therapeutics plans to raise $150 million from 10 million shares priced between $14-$16.